13F filer · CIK 1475373
SECTOR GAMMA AS
OSLO, Q8 · filing since Q2 2013 · last filing Aug 12, 2026
Reported value
$461.0M
+$37.5M vs prior
Positions
40
New / sold out
7 / 9
Added / reduced
19 / 11
Turnover
20.2%
buys $100.3M · sells $89.2M
Top-10 weight
48.4%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | THERMO FISHER SCIENTIFIC INC | +33,584 | – | +$16.8M |
| New | REGENERON PHARMACEUTICALS | +15,780 | – | +$9.8M |
| Added | IQVIA HLDGS INC | +37,714 | +93.7% | +$7.3M |
| New | ASCENDIS PHARMA A/S | +21,305 | – | +$5.7M |
| Added | MEDTRONIC PLC | +71,755 | +25.6% | +$5.6M |
| Added | ABBOTT LABS | +59,912 | +68.4% | +$5.4M |
| Added | GE HEALTHCARE TECHNOLOGIES I | +81,445 | +64.4% | +$5.2M |
| New | BOSTON SCIENTIFIC CORP | +121,128 | – | +$5.2M |
| Added | QIAGEN NV | +125,269 | +77.1% | +$4.9M |
| New | TRAVERE THERAPEUTICS INC | +80,000 | – | +$4.5M |
16 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | UNITEDHEALTH GROUP INC | -36,435 | -100.0% | $-9.9M |
| Reduced | BIOGEN INC | -35,933 | -39.9% | $-7.8M |
| Reduced | AMGEN INC | -20,874 | -44.3% | $-7.6M |
| Sold out | GILEAD SCIENCES INC | -53,247 | -100.0% | $-7.4M |
| Sold out | LANTHEUS HLDGS INC | -93,344 | -100.0% | $-7.1M |
| Reduced | BRUKER CORP | -101,658 | -40.0% | $-6.1M |
| Reduced | BRISTOL-MYERS SQUIBB CO | -101,786 | -12.3% | $-5.9M |
| Reduced | MERCK & CO INC | -43,332 | -16.6% | $-5.6M |
| Sold out | ASCENDIS PHARMA A/S | -21,305 | -100.0% | $-4.9M |
| Reduced | CARDINAL HEALTH INC | -14,208 | -25.9% | $-3.4M |
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB COCOM | 726,115 | $41.8M | 9.08% |
| 2 | MERCK & CO INCCOM | 217,008 | $27.9M | 6.05% |
| 3 | MEDTRONIC PLCSHS | 352,437 | $27.6M | 5.98% |
| 4 | PFIZER INCCOM | 1,004,215 | $24.2M | 5.25% |
| 5 | INCYTE CORPCOM | 170,753 | $19.4M | 4.20% |
| 6 | ELEVANCE HEALTH INC FORMERLYCOM | 44,499 | $17.2M | 3.73% |
| 7 | BIOMARIN PHARMACEUTICAL INCCOM | 294,918 | $16.9M | 3.66% |
| 8 | THERMO FISHER SCIENTIFIC INCCOM | 33,584 | $16.8M | 3.65% |
| 9 | CVSCVS HEALTH CORP | 155,337 | $16.1M | 3.49% |
| 10 | IQVIA HLDGS INCCOM | 77,944 | $15.1M | 3.27% |
30 more rows. Subscribe for $29/month to see every row, download the data and use the API.